Buffalo, NY 12/1/2009 1:20:20 AM
News / Business

HDVA announces new appointed personnel

Health Discovery Corp. has appointed Thomas Gallagher as Executive Vice President and Managing Director of Global IP Strategies.  Gallagher will be in charge of executing new revenue-producing licensing and development relationships in the non-healthcare and high tech industries thereby significantly expanding upon HDC’s focus in the healthcare and personalized medicine arena.

Gallagher has an extensive resume including spending close to fifteen years on Wall Street as a securities and business transaction lawyer, as well as an assistant general counsel managing risk on a transaction and policy basis for a then-$9 billion publicly traded company.  Along with many other experiences Gallagher spent three years working on a pro bono basis for Mother Teresa’s religious order, the Missionaries of Charity, developing and administering the Mother Teresa of Calcutta Center, Inc., and traveling to Kolkata (Calcutta), India, and other locations.  He appears to be what HDVA needs and will bring an abundance of knowledge and experience to this company.

Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter

About Health Discovery Corporation

Health Discovery Corporation is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the emerging field of personalized medicine where such tools are critical to scientific discovery. Its primary business consists of licensing its intellectual property and developing its own product line of biomarker-based diagnostic tests that include human genes and genetic variations, as well as gene, protein, and metabolic expression differences and image analysis in digital pathology and radiology. Members of the Scientific Advisory Board are from time to time invited to provide the Company their professional, objective opinions in their capacity as members of the Scientific Advisory Board. Reference to the Scientific Advisory Board member’s place of employment is for reference only and members’ opinions do not reflect the opinions of their place of employment. 

Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website

 

About Best Damn Penny Stocks

 

Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.

 

Please click here to read the full disclaimer